Corvus Pharmaceuticals In... (CRVS)
NASDAQ: CRVS
· Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT
Corvus Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 88K | 88K | 88K | 246K | 246K | 246K | 246K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 115K | 107K | 108K | 92K | 102K | 117K | 151K | 217K | 187K | 243K | 273K | 272K | 380K | 410K | 460K | 367K | 259K | 137K |
Gross Profit | -27K | -19K | -20K | 154K | 144K | 129K | 95K | -217K | -187K | -243K | -273K | -272K | -380K | -410K | -460K | -367K | -259K | -137K |
Operating Income | -35.54M | -31.22M | -27.55M | -25.09M | -23.4M | -23.09M | -23.41M | -23.42M | -30.34M | -31.73M | -32.56M | -33.71M | -30.28M | -34.56M | -38.63M | -41.7M | -42.5M | -41.97M |
Interest Income | 1.6M | 2.03M | 1.82M | 1.7M | 1.55M | 1.52M | 1.58M | 1.52M | 1.32M | 1.02M | 654K | 343K | 118K | 19K | 11K | 5K | 54K | 209K |
Pretax Income | -45.13M | -41.4M | -62.29M | -56.83M | -22.62M | -24.86M | -27.03M | -30.19M | -39.02M | -40.88M | -41.31M | -40.73M | -36.57M | -39.96M | -43.24M | -6.66M | -5.78M | -4.64M |
Net Income | -45.13M | -41.4M | -62.29M | -56.83M | -22.62M | -24.86M | -27.95M | -37.5M | -46.33M | -48.09M | -47.59M | -40.63M | -36.47M | -39.96M | -43.24M | -6.66M | -5.78M | -4.64M |
Selling & General & Admin | 9.02M | 8.45M | 8.14M | 7.63M | 7.2M | 7.03M | 6.85M | 6.82M | 7.33M | 7.76M | 8.1M | 8.53M | 8.48M | 8.57M | 9.52M | 10.18M | 11.35M | 12.08M |
Research & Development | 26.52M | 22.76M | 19.39M | 17.41M | 16.15M | 16.01M | 16.53M | 16.61M | 23.01M | 23.96M | 24.47M | 25.18M | 21.8M | 25.98M | 29.11M | 31.52M | 31.15M | 29.9M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 56K | 204K | 204K | 350K | 440K | 433K | 527K | 381K | 235K | 94K | n/a | n/a |
Operating Expenses | 35.54M | 31.22M | 27.52M | 25.04M | 23.35M | 23.04M | 23.38M | 23.42M | 30.34M | 31.73M | 32.56M | 33.71M | 30.28M | 34.56M | 38.63M | 41.7M | 42.5M | 41.97M |
Interest Expense | 639K | n/a | n/a | n/a | n/a | n/a | n/a | 329K | 329K | 329K | 329K | 8K | 19K | 19K | 19K | 11K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -23K | -51K | -51K | -51K | -28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 35.54M | 31.22M | 27.55M | 25.09M | 23.4M | 23.09M | 23.41M | 23.42M | 30.34M | 31.73M | 32.56M | 33.71M | 30.28M | 34.56M | 38.63M | 41.7M | 42.5M | 41.97M |
Income Tax Expense | n/a | n/a | -20.28K | -20.28K | -20.28K | -20.28K | 923K | 7.31M | 7.31M | 7.21M | 6.28M | -92K | -92K | 7K | 4K | -147K | -147K | -146K |
Shares Outstanding (Basic) | 77.77M | 72.13M | 68.35M | 66.7M | 59.71M | 47.51M | 48.02M | 48.97M | 47.5M | 46.56M | 46.55M | 46.55M | 46.55M | 46.55M | 46.55M | 43.95M | 42.25M | 34.52M |
Shares Outstanding (Diluted) | 77.77M | 75.15M | 68.35M | 66.7M | 59.71M | 49.04M | 48.02M | 48.97M | 47.5M | 46.56M | 46.55M | 46.55M | 46.55M | 46.55M | 46.55M | 43.95M | 42.25M | 34.52M |
EPS (Basic) | -0.67 | -0.64 | -0.97 | -0.93 | -0.45 | -0.52 | -0.59 | -0.8 | -1 | -1.04 | -1.03 | -0.88 | -0.8 | -0.9 | -1.06 | 0.06 | -0.03 | -0.11 |
EPS (Diluted) | -1.01 | -0.98 | -0.97 | -0.93 | -0.45 | -0.52 | -0.59 | -0.8 | -1 | -1.04 | -1.03 | -0.88 | -0.8 | -0.9 | -1.06 | 0.06 | -0.03 | -0.11 |
EBITDA | -35.48M | -31.13M | -27.46M | -25M | -23.3M | -22.97M | -23.26M | -23.2M | -30.05M | -31.39M | -32.2M | -35.76M | -33.94M | -38.18M | -42.2M | -42.8M | -41.95M | -41.39M |
EBIT | -33.28M | -31.22M | -27.55M | -25.07M | -23.38M | -23.06M | -23.33M | -23.22M | -29.98M | -31.23M | -31.98M | -35.69M | -34.03M | -38.46M | -42.67M | -43.33M | -42.5M | -41.97M |
Depreciation & Amortization | 92K | 84K | 85K | 93K | 102K | 117K | 151K | 217K | 281K | 337K | 367K | 366K | 380K | 410K | 460K | 509K | 548K | 585K |